Ask AI

ClinicalThought

Share

Program Content

Activities

  • Belantamab Mafodotin for R/R MM
    My Take on the Recent Approval of Belantamab Mafodotin for Relapsed/Refractory Multiple Myeloma
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 25, 2020

  • MM Biochemical Relapse
    Should We Treat Biochemical Relapse in Multiple Myeloma?
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: September 22, 2020

Provided by

ProCE Banner

Supporters

GlaxoSmithKline